[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

EP1763358A4 - Compositions et methodes coupe-faim - Google Patents

Compositions et methodes coupe-faim

Info

Publication number
EP1763358A4
EP1763358A4 EP05732122A EP05732122A EP1763358A4 EP 1763358 A4 EP1763358 A4 EP 1763358A4 EP 05732122 A EP05732122 A EP 05732122A EP 05732122 A EP05732122 A EP 05732122A EP 1763358 A4 EP1763358 A4 EP 1763358A4
Authority
EP
European Patent Office
Prior art keywords
appetite
methods
suppressing compositions
suppressing
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP05732122A
Other languages
German (de)
English (en)
Other versions
EP1763358A1 (fr
Inventor
Ilya Raskin
Joseph M O'neal Iii
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rutgers State University of New Jersey
Original Assignee
Rutgers State University of New Jersey
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rutgers State University of New Jersey filed Critical Rutgers State University of New Jersey
Publication of EP1763358A1 publication Critical patent/EP1763358A1/fr
Publication of EP1763358A4 publication Critical patent/EP1763358A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/27—Asclepiadaceae (Milkweed family), e.g. hoya
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Rheumatology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
EP05732122A 2004-04-07 2005-04-07 Compositions et methodes coupe-faim Withdrawn EP1763358A4 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US56014404P 2004-04-07 2004-04-07
PCT/US2005/011632 WO2005099737A1 (fr) 2004-04-07 2005-04-07 Compositions et méthodes coupe-faim

Publications (2)

Publication Number Publication Date
EP1763358A1 EP1763358A1 (fr) 2007-03-21
EP1763358A4 true EP1763358A4 (fr) 2010-03-24

Family

ID=35149773

Family Applications (1)

Application Number Title Priority Date Filing Date
EP05732122A Withdrawn EP1763358A4 (fr) 2004-04-07 2005-04-07 Compositions et methodes coupe-faim

Country Status (7)

Country Link
US (2) US7265101B2 (fr)
EP (1) EP1763358A4 (fr)
JP (1) JP4881294B2 (fr)
CN (1) CN1972701A (fr)
AU (1) AU2005232633B2 (fr)
CA (1) CA2563237C (fr)
WO (1) WO2005099737A1 (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE395558T1 (de) * 2002-06-20 2008-05-15 Eveready Battery Inc Beleuchtungsvorrichtung mit einstellbarem scheinwerferstrahl
JP4881294B2 (ja) * 2004-04-07 2012-02-22 ラトガーズ， ザ ステイト ユニバーシティ オブ ニュー ジャージー 食欲抑制性組成物及び方法
US20060083795A1 (en) * 2004-10-19 2006-04-20 Lima Shatkina Meal replacement products having appetite suppressing qualities
CA2550272A1 (fr) * 2005-06-17 2006-12-17 Smartburn Formulations Ltd. Supplement dietetique qui entraine une perte de poids rapide, controle l'appetit, controle le stress, aide a relaxer, combat la fatigue et favorise le bien-etre mental
US8945652B2 (en) 2005-11-23 2015-02-03 The Coca-Cola Company High-potency sweetener for weight management and compositions sweetened therewith
MX2009001571A (es) * 2006-08-17 2009-02-19 Unilever Nv Proceso para la produccion de la planta de hoodia que contiene glucosidos esteroides.
DE102006048530A1 (de) * 2006-10-13 2008-04-17 Cognis Ip Management Gmbh Zubereitungen zur oralen Aufnahme (II)
US20080188447A1 (en) * 2007-02-02 2008-08-07 Svyatoslav Komarnytsky Glucocorticoid-lowering composition
US20090041902A1 (en) * 2007-08-10 2009-02-12 Jadwiga Malgorzata Bialek Composite food product in a pack comprising fibers and method for preparing such product
EP2080517A1 (fr) 2008-01-18 2009-07-22 Unilever N.V. Processus pour obtenir un produit végétal sec
US20090324757A1 (en) * 2008-03-31 2009-12-31 Rutgers, The State University Of New Jersey Compositions and Methods for Modulating Visceral Sensation and/or Gastrointestinal Reflex Activity
US7923435B2 (en) * 2008-04-21 2011-04-12 Phytopharm Plc Hoodia plant extract with improved flavor
US20090263510A1 (en) 2008-04-21 2009-10-22 Conopco, Inc., D/B/A Unilever Process of making Hoodia plant extract with improved flavor
WO2012022880A2 (fr) 2010-07-29 2012-02-23 Universite De Strasbourg Procede de synthese de steroïdes

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002047708A2 (fr) * 2000-12-15 2002-06-20 Pharmacia Corporation Inhibition selective de cox-2 a partir d'extraits de plantes comestibles
US20030152648A1 (en) * 2001-11-16 2003-08-14 Corley David Gregory Plant derived or derivable material with appetite suppressing activity

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6352713B1 (en) * 1999-12-01 2002-03-05 Drugtech Corporation Nutritional composition
EE9900497A (et) * 1997-04-15 2000-06-15 Csir Söögiisu pärssiva toimega farmatseutilised kompositsioonid
US5906825A (en) * 1997-10-20 1999-05-25 Magellan Companies, Inc. Polymers containing antimicrobial agents and methods for making and using same
US20040062802A1 (en) * 1998-04-02 2004-04-01 Hermelin Victor M. Maximizing effectiveness of substances used to improve health and well being
US6482943B1 (en) * 1999-04-30 2002-11-19 Slil Biomedical Corporation Quinones as disease therapies
US6479545B1 (en) * 1999-09-30 2002-11-12 Drugtech Corporation Formulation for menopausal women
US7416746B2 (en) * 2001-09-07 2008-08-26 Peter Grandics Method for cancer therapy using herbal extracts
US20030157185A1 (en) * 2002-02-08 2003-08-21 Lou Paradise Topical treatment of neuropathy
US20040265398A1 (en) * 2002-04-25 2004-12-30 Fleischner Albert M. Herbal composition for weight control
JP3665049B2 (ja) * 2002-10-16 2005-06-29 株式会社ノエビア 細胞賦活剤、抗酸化剤、及び皮膚外用剤
US7067124B2 (en) * 2003-03-28 2006-06-27 National Enzyme Company Protease composition and method for treating a digestive disorder
JP2005008572A (ja) * 2003-06-19 2005-01-13 Yakult Honsha Co Ltd リパーゼ阻害剤
US20050031761A1 (en) * 2003-08-05 2005-02-10 Donald Brucker Methods of producing a functionalized coffee
JP4881294B2 (ja) * 2004-04-07 2012-02-22 ラトガーズ， ザ ステイト ユニバーシティ オブ ニュー ジャージー 食欲抑制性組成物及び方法
US20080188447A1 (en) * 2007-02-02 2008-08-07 Svyatoslav Komarnytsky Glucocorticoid-lowering composition
US20090324757A1 (en) * 2008-03-31 2009-12-31 Rutgers, The State University Of New Jersey Compositions and Methods for Modulating Visceral Sensation and/or Gastrointestinal Reflex Activity

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002047708A2 (fr) * 2000-12-15 2002-06-20 Pharmacia Corporation Inhibition selective de cox-2 a partir d'extraits de plantes comestibles
US20030152648A1 (en) * 2001-11-16 2003-08-14 Corley David Gregory Plant derived or derivable material with appetite suppressing activity

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
CATHERINE C. NETO ET AL: "Antibacterial activity of some Peruvian medicinal plants from the Callejon de Huaylas", JOURNAL OF ETHNOPHARMACOLOGY, vol. 79, 2002, pages 133 - 138 *
DATABASE BIOSIS [online] BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US; 1993, ROTENBERG P ET AL: "Investigation of the effect of some phenolic fraction on HeLa cell cultures development", XP007919257, Database accession no. PREV199598239717 *
REVUE ROUMAINE DE BIOLOGIE SERIE DE BIOLOGIE ANIMALE, vol. 38, no. 1, 1993, pages 63 - 69, ISSN: 0377-8142 *
S. MORRIS KUPCHAN ET AL: "Calotropin, a Cytotoxic Principle Isolated from Asclepias curassavica L.", SCIENCE, vol. 146, no. 3652, 25 December 1964 (1964-12-25), pages 1685 - 1686, XP007919259 *
See also references of WO2005099737A1 *
WARASHINA T ET AL: "Steroidal glycosides and cardenolide glycosides from Asclepias fruticosa", PHYTOCHEMISTRY, PERGAMON PRESS, GB, vol. 37, no. 1, 1 January 1994 (1994-01-01), pages 217 - 226, XP026630905, ISSN: 0031-9422, [retrieved on 19940101] *

Also Published As

Publication number Publication date
JP2007532553A (ja) 2007-11-15
EP1763358A1 (fr) 2007-03-21
US7265101B2 (en) 2007-09-04
CN1972701A (zh) 2007-05-30
CA2563237A1 (fr) 2005-10-27
WO2005099737A1 (fr) 2005-10-27
CA2563237C (fr) 2012-10-09
US20060084638A1 (en) 2006-04-20
AU2005232633A1 (en) 2005-10-27
JP4881294B2 (ja) 2012-02-22
US20080038389A1 (en) 2008-02-14
AU2005232633B2 (en) 2011-06-16

Similar Documents

Publication Publication Date Title
IL181543A0 (en) Dendrimer based compositions and methods of using the same
GB0422525D0 (en) Dermatological compositions and methods
IL191072A0 (en) Therapeutic compositions and methods
EP1776148A4 (fr) Dispositifs ophtalmiques et procedes et compositions associes
EP1895838A4 (fr) Preparations et methodes
IL183581A0 (en) Viscosupplementation devices and compositions
EP1968526A4 (fr) Compositions dentaires moussantes et procedes
ZA200704295B (en) Arthrospira-based compositions and uses thereof
HK1109576A1 (en) Aequorin-containing compositions and methods of using same
IL184062A0 (en) Visco-supplement composition and methods
EP1735456A4 (fr) Compositions poylmeres et procedes associes d'utilisation
PL1838150T3 (pl) Kompozycje pestycydu i sposoby
EP1763358A4 (fr) Compositions et methodes coupe-faim
ZA200605722B (en) Composition and method
EP1773386A4 (fr) Compositions vaccinales et methodes correspondantes
EP1807071A4 (fr) Methodes et compositions antipyretiques
EP1807512A4 (fr) Compositions et méthodes de transcription inverse
EP1769007A4 (fr) Compositions polymeres et procedes d'utilisation associes
GB0424051D0 (en) Compounds and compositions
ZA200706038B (en) Visco-supplement composition and methods
GB0501348D0 (en) Compositions and methods
GB0428034D0 (en) Compositions and methods
GB0517546D0 (en) Therapeutic methods and compositions
EP1841406A4 (fr) Procedes et formulations
GB0418363D0 (en) Therapeutic methods and compositions for use therein

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20061107

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR

DAX Request for extension of the european patent (deleted)
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1101552

Country of ref document: HK

A4 Supplementary search report drawn up and despatched

Effective date: 20100219

17Q First examination report despatched

Effective date: 20110301

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 36/27 20060101ALI20151007BHEP

Ipc: A61K 31/56 20060101AFI20151007BHEP

Ipc: A61P 3/04 20060101ALI20151007BHEP

INTG Intention to grant announced

Effective date: 20151021

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20160301

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1101552

Country of ref document: HK